• S-Biomedic announces completion of prestigious financing with European Innovation Council Fund

    Friday October 1st 2021

  • Biotalys strengthens executive team with the appointment of Patrick McDonnell as Chief Business Officer

    Thursday September 30th 2021

  • OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

    Thursday September 30th 2021

  • Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

    Wednesday September 29th 2021

  • Mithra announces topline results for COVID-19 Phase II Study

    Friday September 24th 2021

  • Biocartis announces restart of its high-throughput cartridge manufacturing line

    Thursday September 23rd 2021

  • Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer

    Wednesday September 22nd 2021

  • Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study

    Wednesday September 22nd 2021

  • Your news here?

  • Mithra announces an update on PeriNesta®

    Wednesday September 22nd 2021

  • Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer

    Tuesday September 21st 2021

  • Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis

    Friday September 17th 2021


Strategic Partners